Neutralizing Antibody Responses in COVID-19 Convalescent Sera

Passive transfer of antibodies from COVID-19 convalescent patients is being used as an experimental treatment for eligible patients with SARS-CoV-2 infections. The United States Food and Drug Administration’s (FDA) guidelines for convalescent plasma initially recommended target antibody titers of 16...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Lee, William T, Girardin, Roxanne C, Dupuis, Alan P, Kulas, Karen E, Payne, Anne F, Wong, Susan J, Arinsburg, Suzanne, Nguyen, Freddy T, Mendu, Damodara Rao, Firpo-Betancourt, Adolfo, Jhang, Jeffrey, Wajnberg, Ania, Krammer, Florian, Cordon-Cardo, Carlos, Amler, Sherlita, Montecalvo, Marisa, Hutton, Brad, Taylor, Jill, McDonough, Kathleen A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665673/
https://ncbi.nlm.nih.gov/pubmed/33104179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa673
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars